Surveillance Systems from Public Health Institutions and Scientific Societies for Antimicrobial Resistance and Healthcare-Associated Infections in Europe (SUSPIRE): protocol for a systematic review
BMJ Publishing Group, 2017
Online
academicJournal
Zugriff:
TRIAL REGISTRATION NUMBER: CRD42016033867. ; The worldwide spread of antimicrobial resistance is now recognised as a global public health threat. Owing to the geographical heterogeneity, complexity and continuously evolving dynamics of resistant organisms and genes, surveillance is a key tool for understanding, measuring and informing actions in the fight against this problem. To date there is no harmonisation of key indicators or of methodologies used to obtain them. ; Yes
Titel: |
Surveillance Systems from Public Health Institutions and Scientific Societies for Antimicrobial Resistance and Healthcare-Associated Infections in Europe (SUSPIRE): protocol for a systematic review
|
---|---|
Autor/in / Beteiligte Person: | Núñez-Núñez, María ; Navarro, María Dolores ; Gkolia, Panagiota ; Babu Rajendran, Nithya ; Del Toro, María Dolores ; Voss, Andreas ; Sharland, Mike ; Sifakis, Frangiscos ; Tacconelli, Evelina ; Rodríguez-Baño, Jesús ; EPI-NET group on behalf of COMBACTE-MAGNET Consortium. ; Núñez-Núñez,M ; Navarro, MD ; Del Toro, MD ; Rodríguez-Baño, J Unit of Infectious Disease, Microbiology, and Preventive Medicine, Institute of Biomedicine of Seville (IBIS)/University Hospital Virgen Macarena-Virgen del Rocío/Spanish National Research Council (CSIC), Seville, Spain. Departamento de Medicina, Universidad de Sevilla, Seville, Spain. Núñez-Núñez, M Department of Pharmacy, University Hospital Virgen Macarena, Seville, Spain. Gkolia, P ; Babu Rajendran, N ; Tacconelli, E Infectious Diseases, Internal Medicine 1, DZIF Center, Tuebingen University Hospital, Tuebingen, Germany. Voss, A Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands. Sharland, M Paediatric Infectious Diseases Research Group, St George's University London, London, UK. Sifakis, F AstraZeneca LP, Gaithersburg, Maryland, USA. ; Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115737 resources of which are composed of financial contribution from the European Union Seventh Framework Programme (FP7/2007/2013) and EFPIA companies in kind contribution. JRB also received funding for research from Ministerio de Economía y Competitividad, Instituto de Salud Carlos III—cofinanced by European Development Regional Fund ‘A way to achieve Europe’ ERDF, Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015). |
Link: | |
Veröffentlichung: | BMJ Publishing Group, 2017 |
Medientyp: | academicJournal |
ISSN: | 2834-8192 (print) ; 2044-6055 (print) |
DOI: | 10.1136/bmjopen-2016-014538 |
Schlagwort: |
|
Sonstiges: |
|